Skip to main content
. Author manuscript; available in PMC: 2016 Jun 9.
Published in final edited form as: Sci Transl Med. 2015 Oct 14;7(309):309ra163. doi: 10.1126/scitranslmed.aab0195

Table 2. Evaluation of classifiers as indicators of tumor infiltration.

Nuclear density, axonal density, and protein:lipid ratio were measured for each of the 1477 300×300 μm2 FOVs from 51 fresh tissue biopsies from 18 patients. A quasi-likelihood approach with a GAM was used to incorporate all of the attributes into a single classifier. Half of the FOVs (n=738) were used to create the classifier, which was then tested on the other half of the data (n=739). Given that glioma can be more difficult to distinguish from normal tissue than metastases and extra-axial tumors, a quasi-likelihood generalized additive model (GAM) was also used on a subset of tumors, excluding all non-glial tumors, to create the glioma-only classifier. To eliminate correlation between the testing set and training set, we used a leave-one-out cross-validation approach. The leave-one-out cross-validation was performed in a data set excluding non-glioma patients.

Classification condition Area under curve Mean sensitivity (%) 95% CI Mean specificity (%) 95% CI
GAM (all subjects)

Normal vs. abnormal 0.995 97.5 95.9–98.9 98.5 97.0–99.7
Normal vs. infiltrating 0.988 94.7 91.4–98.9 98.5 97.0–99.5
Normal vs. dense 0.989 98.0 95.6–100 99.0 97.4–100

GAM (glioma only)

Normal vs. abnormal 0.994 97.0 95.0–98.7 98.7 97.2–99.5
Normal vs. infiltrating 0.988 94.9 91.3–98.1 98.5 97.1–99.5
Normal vs. dense 0.990 98.2 95.1–100 99.0 98.2–100

Leave-one-out cross-validation

Normal vs. abnormal 0.893 87.3 n/a 87.5 n/a
Normal vs. infiltrating 0.911 82.8 n/a 95 n/a
Normal vs. dense 0.908 83.9 n/a 93.3 n/a

CI, confidence interval.

HHS Vulnerability Disclosure